Sullivan DM - Search Results

1

The 2010 Health Care Reform Act: a potential opportunity to advance cancer research by taking cancer personally.

Dalton WS, Sullivan DM, Yeatman TJ, Fenstermacher DA. Dalton WS, et al. Among authors: sullivan dm. Clin Cancer Res. 2010 Dec 15;16(24):5987-96. doi: 10.1158/1078-0432.CCR-10-1216. Clin Cancer Res. 2010. PMID: 21169252 Review.

2

On the eve of personalized medicine in oncology.

Yeatman TJ, Mule J, Dalton WS, Sullivan D. Yeatman TJ, et al. Cancer Res. 2008 Sep 15;68(18):7250-2. doi: 10.1158/0008-5472.CAN-08-1374. Cancer Res. 2008. PMID: 18794109 Free PMC article. No abstract available.

3

Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells.

Hazlehurst LA, Argilagos RF, Emmons M, Boulware D, Beam CA, Sullivan DM, Dalton WS. Hazlehurst LA, et al. Among authors: sullivan dm. Cancer Res. 2006 Feb 15;66(4):2338-45. doi: 10.1158/0008-5472.CAN-05-3256. Cancer Res. 2006. PMID: 16489039

4

Phase I study of a novel taxane BMS-188797 in adult patients with solid malignancies.

Garrett CR, Fishman MN, Rago RR, Williams CC, Dellaportas AM, Mahany JJ, Lush RM, Dalton WS, Gollerkeri A, Cohen MB, Sullivan DM. Garrett CR, et al. Among authors: sullivan dm. Clin Cancer Res. 2005 May 1;11(9):3335-41. doi: 10.1158/1078-0432.CCR-04-1494. Clin Cancer Res. 2005. PMID: 15867232 Clinical Trial.

5

The creation of an integrated health-information platform: building the framework to support personalized medicine.

Wenham RM, Sullivan DM, Hulse M, Jacobsen PB, Dalton WS. Wenham RM, et al. Among authors: sullivan dm. Per Med. 2012 Aug;9(6):621-632. doi: 10.2217/pme.12.76. Per Med. 2012. PMID: 29768801

6

Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma.

Turner JG, Cui Y, Bauer AA, Dawson JL, Gomez JA, Kim J, Cubitt CL, Nishihori T, Dalton WS, Sullivan DM. Turner JG, et al. Among authors: sullivan dm. Cancer Res. 2020 Dec 1;80(23):5344-5354. doi: 10.1158/0008-5472.CAN-19-0677. Epub 2020 Oct 6. Cancer Res. 2020. PMID: 33023948 Free PMC article.

7

Patient Enrichment for Precision-Based Cancer Clinical Trials: Using Prospective Cohort Surveillance as an Approach to Improve Clinical Trials.

Dalton WS, Sullivan D, Ecsedy J, Caligiuri MA. Dalton WS, et al. Clin Pharmacol Ther. 2018 Jul;104(1):23-26. doi: 10.1002/cpt.1051. Epub 2018 Mar 23. Clin Pharmacol Ther. 2018. PMID: 29570791 Free PMC article.

8

Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy.

Nefedova Y, Sullivan DM, Bolick SC, Dalton WS, Gabrilovich DI. Nefedova Y, et al. Among authors: sullivan dm. Blood. 2008 Feb 15;111(4):2220-9. doi: 10.1182/blood-2007-07-102632. Epub 2007 Nov 26. Blood. 2008. PMID: 18039953 Free article.

9

Combined inhibition of Notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect.

Li M, Chen F, Clifton N, Sullivan DM, Dalton WS, Gabrilovich DI, Nefedova Y. Li M, et al. Among authors: sullivan dm. Mol Cancer Ther. 2010 Dec;9(12):3200-9. doi: 10.1158/1535-7163.MCT-10-0372. Mol Cancer Ther. 2010. PMID: 21159606 Free PMC article.

10

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility.

Li B, Eschrich SA, Berglund A, Mitchell M, Fenstermacher D, Danaee H, Dai H, Sullivan D, Trepicchio WL, Dalton WS. Li B, et al. JMIR Res Protoc. 2017 Mar 20;6(3):e45. doi: 10.2196/resprot.7289. JMIR Res Protoc. 2017. PMID: 28320689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page